No black box warning on record for Tpoxx

As of the latest FDA labeling reviewed, Tpoxx (TECOVIRIMAT MONOHYDRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tpoxx medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypoglycemia: Co-administration with repaglinide may cause hypoglycemia. Monitor blood glucose and monitor for hypoglycemic symptoms during co-administration. ( 5.1 ) 5.1 Hypoglycemia When Co-Administered with Repaglinide Co-administration of repaglinide and tecovirimat may cause mild to moderate hypoglycemia. Monitor blood glucose and monitor for hypoglycemic symptoms w

No black box warning on record for Tpoxx

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypoglycemia: Co-administration with repaglinide may cause hypoglycemia. Monitor blood glucose and monitor for hypoglycemic symptoms during co-administration. ( 5.1 ) 5.1 Hypoglycemia When Co-Administered with Repaglinide Co-administration of repaglinide and tecovirimat may cause mild to moderate hypoglycemia. Monitor blood glucose and monitor for hypoglycemic symptoms w

Tpoxx Black Box Warning

No black box warning on record for Tpoxx

Other warnings & precautions

Tpoxx Black Box Warning

No black box warning on record for Tpoxx

Other warnings & precautions